Radiobiological modifiers in clinical radiation oncology: current reality and future potential.

about

Heat-killed salmonella typhimurium (HKST) protects mice against radiation in TLR4-dependent manner.Minimizing morbidity in radiation oncology: a special issue from Future Oncology.

P2860

Q42366530-F20A7672-3E4A-431A-BE7D-D7C30CAD09F7 Q48661490-4A70266B-A6D4-4769-837D-185525EB8437

P2860

Radiobiological modifiers in clinical radiation oncology: current reality and future potential.

Item

http://www.wikidata.org/entity/Q38294597

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Radiobiological modifiers in c ...... reality and future potential.

@en

type

Item

label

Radiobiological modifiers in c ...... reality and future potential.

@en

prefLabel

Radiobiological modifiers in c ...... reality and future potential.

@en

P1476

Radiobiological modifiers in c ...... reality and future potential.

@en

P2093

Ron R Allison

http://www.w3.org/2001/XMLSchema#string

P2860

A Radiobiological Review on Melatonin: A Novel Radioprotector

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls

The DNA-damage response in human biology and disease

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group

Fibroblast growth factor receptors, developmental corruption and malignant disease

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer

Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators

Palifermin for oral mucositis after intensive therapy for hematologic cancers

P304

2359-2379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.14.174

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25525845

http://www.w3.org/2001/XMLSchema#string

Radiobiological modifiers in clinical radiation oncology: current reality and future potential.

about

P2860

P2860

Radiobiological modifiers in clinical radiation oncology: current reality and future potential.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698